Exos Asset Management’s SkinHealth Systems SKIN Stock Holding History

Exos Asset Management’s Portfolio SKIN Stock Details SKIN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-1,006	Closed	-$338K	–	671
2021 Q2	$338K	Sell	1,006 -70	-7%	-$19.1K	0.18%	189
2021 Q1	$232K	Buy	+1,076	New	+$237K	0.18%	192

Other funds holding SKIN

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

LCG

Luxor Capital Group New York $2.52B AUM 29.31% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

Exos Asset Management's SKIN Position: Q3 2021 in Review

Exos Asset Management sold out of SkinHealth Systems (SKIN) in Q3 2021, closing a stake of 1,006 shares — an estimated $338K sold.

Exos Asset Management first reported a position in SKIN in Q1 2021 and held it in 2 quarters. The position peaked at $338K in Q2 2021. 165 funds tracked by Wall St. Rank hold SKIN as of Q3 2021.

Exos Asset Management reported no remaining SkinHealth Systems position as of Q3 2021 after selling out during the quarter.
Exos Asset Management sold 1,006 SkinHealth Systems shares in Q3 2021, an estimated $338K.
Exos Asset Management first reported a position in SkinHealth Systems in Q1 2021 and held it in 2 quarters.
Exos Asset Management's SkinHealth Systems position peaked at $338K in Q2 2021.
165 funds tracked by Wall St. Rank held SkinHealth Systems as of Q3 2021.

Based on Exos Asset Management's 13F filing for Q3 2021, filed 25 Oct 2021.